VCBeat Health Contact Us
Home Abogen Biosciences Appoints Dr. Jijun Yuan as Executive Vice President and Head of Oncology R&D

Abogen Biosciences Appoints Dr. Jijun Yuan as Executive Vice President and Head of Oncology R&D

Jan 05, 2022 09:45 CST Updated 09:45
Abogen

Nucleic Acid Drug Developer

On January 4, 2022, Abogen announced the appointment of Dr. Ji-Jun Yuan as the company's Head of Oncology Research and Executive Vice President, responsible for leading the research efforts in the company’s oncology pipeline.

*Disclaimer: This article was written by an author who has settled in Sina Medicine News. The views expressed represent those of the author and do not reflect the position of Sina Medicine News.